On April 17th of 2014, the FDA issued a critical safety communication, one that discussed a potentially life-threatening associated risk between power morcellators and a serious, aggressive cancer. To find out if you are eligible to participate in the power morcellator lawsuit, please call us at 1.866.472.9108 or contact us online.
Here’s is what you need to know:
- “Lapraroscopic Power Morcellators” are medical devices used for a variety of minimally invasive surgeries, including removing uterine fibroids (myomectomy) and performing hysterectomies.
- Power morcellators work by breaking up and removing small amounts of tissue via a small incision site (thus, the benefit to the patient).
- For women whose surgeries involved the use of a power morcellators, there may be a risk of spreading cancerous tissue, especially uterine sarcomas.
- The power morcellator’s associated risk of spreading cancerous tissue has two causes: 1) There are some cancerous tissues that cannot be identified until they have been removed and inspected. Therefore, a woman could have a hysterectomy thinking she is cancer-free, only to find out after the surgery that she is not; and 2) Power morcellators have a unique ability to break up tissue — some, and we’d hope most, of this tissue is removed via the device, but some may unfortunately be re-dispersed throughout the body during this procedure.
There is good news, though.
First, if you are a woman suffering from uterine fibroids and considering surgery, there may be other, safer surgical options available to you.
However, if you or someone you know underwent power morcellation to have fibroids removed and later developed cancer, you may be eligible to file a power morcellator lawsuit – a lawsuit that could help you receive compensation for your high medical expenses while also fighting for the future by STANDING UP TO THE MANUFACTURERS OF DEFECTIVE MEDICAL DEVICES!
Power morcellators were touted as a minimally invasive surgery with a low recovery time for women, and while they may be true for most, it is not true for all.